Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SPECIALLÆGESELSKABET AARHUS ØJENKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 1.5% 0.7%   Bankruptcy risk   1.4% 2.1% 1.9% 1.3% 1.4% 1.5% 14.8% 12.3%   Credit score (0-100)   80 69 69 78 78 75 14 19   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   34.0 0.1 0.4 36.9 35.5 19.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,843 2,810 2,657 3,038 3,435 3,298 0.0 0.0   EBITDA   1,633 461 476 1,174 1,650 1,203 0.0 0.0   EBIT   1,541 370 363 1,082 1,589 1,149 0.0 0.0   Pre-tax profit (PTP)   1,542.5 367.5 355.3 1,059.3 1,519.5 1,043.3 0.0 0.0   Net earnings   1,203.5 299.5 277.3 820.3 1,181.5 821.0 0.0 0.0   Pre-tax profit without non-rec. items   1,542 368 355 1,059 1,520 1,043 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   186 367 253 161 100 46.1 0.0 0.0   Shareholders equity total   1,614 714 741 1,311 1,693 1,414 589 589   Interest-bearing liabilities   714 1,151 1,188 1,228 1,590 1,864 0.0 0.0   Balance sheet total (assets)   2,962 2,220 2,476 3,134 3,927 3,887 589 589   Net Debt   -1,072 708 141 -702 -1,798 -1,757 -589 -589     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,843 2,810 2,657 3,038 3,435 3,298 0.0 0.0   Gross profit growth   -4.2% -1.2% -5.4% 14.3% 13.1% -4.0% -100.0% 0.0%   Employees   6 4 4 4 2 2 0 0   Employee growth %   100.0% -33.3% 0.0% 0.0% -50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,962 2,220 2,476 3,134 3,927 3,887 589 589   Balance sheet change%   69.7% -25.1% 11.5% 26.6% 25.3% -1.0% -84.9% 0.0%   Added value   1,633.4 461.5 475.8 1,173.6 1,680.5 1,202.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -184 89 -226 -184 -122 -109 -46 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   54.2% 13.2% 13.6% 35.6% 46.3% 34.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   66.3% 15.6% 17.1% 39.7% 45.0% 29.4% 0.0% 0.0%   ROI %   85.7% 19.3% 20.8% 48.2% 53.9% 35.0% 0.0% 0.0%   ROE %   88.3% 25.7% 38.1% 80.0% 78.7% 52.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   54.5% 32.1% 29.9% 41.8% 43.1% 36.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -65.6% 153.5% 29.7% -59.8% -109.0% -146.1% 0.0% 0.0%   Gearing %   44.2% 161.3% 160.3% 93.7% 93.9% 131.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.9% 4.0% 4.0% 4.4% 4.9% 6.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.0 1.2 1.3 1.7 1.7 1.5 0.0 0.0   Current Ratio   2.0 1.2 1.3 1.7 1.7 1.5 0.0 0.0   Cash and cash equivalent   1,785.6 442.6 1,046.2 1,929.6 3,388.2 3,621.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,405.5 324.8 538.7 1,200.9 1,569.9 1,345.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   272 115 119 293 840 601 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   272 115 119 293 825 601 0 0   EBIT / employee   257 92 91 270 794 574 0 0   Net earnings / employee   201 75 69 205 591 411 0 0